EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Circular Permutation of the E. coli Heat-Labile Enterotoxin Pentameric B Subunit for Mucosal Vaccine Adjuvant Design

Sheng-Han Hsu, Da-You Xie, Cheng-Yen Tsai, Wei-Shuo Lin, Chu-Ya Wu, Yi-Hung Lin, Wen-Chun Liu, Suh-Chin Wu, Shih-Che Sue iD

ACS Omega · 10.02.2026 · 11 (5) · 8784-8798

DOI: 10.1021/acsomega.5c12660 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Omega, online erschienen am 25.01.2026. Verfasst von Sheng-Han Hsu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Bioinformatics and Structural Biology, National Tsing Hua University, 101, Section 2, Kuang-Fu Road, Hsinchu 300044, Taiwan. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Technology, Taiwan.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High Resolution Image Download MS PowerPoint Slide The heat-labile enterotoxins (LTs) of Escherichia coli structurally belong to the AB 5 toxin, which consists of an A subunit and a pentameric B subunit. LTs have been extensively reported for their potent mucosal adjuvant activities. The B subunit of type II LT (LT-IIb-B 5 ) recognizes the GD1a ganglioside, which is associated with the internalization of the toxic A subunit and meanwhile involved in the recognition of the Toll-like receptor (TLR-2/1) and downstream NF-κB activation. In developing LT-IIb-B 5 as a safe adjuvant, we intend to prevent concerns derived from the intrinsic toxicity of LT. A strategy of circular permutation (CP) is used to design a new LT-IIb-B 5 pentamer. By replacing the backbone opening at the GD1a-binding site, the GD1a-binding site becomes deficient and GD1a-binding ability is removed, yet TLR-2/1 activation is maintained. The novel LT-IIb-B 5 pentamer has no GD1a-mediated cell toxicity but maintains sufficient immunoreactivity. We identified a potent CP candidate (CP 13–14 ) with a backbone opening at position 13–14, exhibiting greater protective potential against an influenza viral challenge than the native LT-IIb-B 5 in a mouse model. In the intranasal vaccination using trivalent neuraminidase proteins formulated with LT-IIb-B 5 CP 13–14, we demonstrated complete protection against heterologous H1N1 and H3N2 viral challenge infections. This study purposes for a new design for LT-IIb-B 5 protein adjuvant and addresses the urgent need for a novel, efficient, and safer mucosal adjuvant for respiratory diseases.

Autor:innen und Institutionen

  • Institute of Bioinformatics and Structural Biology, National Tsing Hua University, 101, Section 2, Kuang-Fu Road, Hsinchu 300044, Taiwan.
  • Institute of Biotechnology, National Tsing Hua University, 101, Section 2, Kuang-Fu Road, Hsinchu 300044, Taiwan.
  • Instrumentation Center, National Tsing Hua University, 101, Section 2, Kuang-Fu Road, Hsinchu 300044, Taiwan.
  • National Synchrotron Radiation Research Center, 101 Hsin-Ann Road, Hsinchu Science Park, Hsinchu 300092, Taiwan.
  • Biomedical Translation Research Center, Academia Sinica, 128 Section 2, Academia Road, Nankang, Taipei 115201, Taiwan.

ORCID-Profile: Shih-Che Sue

Förderung

  • Ministry of Science and Technology, Taiwan

Zitieren

APA

Hsu, S. H., Xie, D. Y., Tsai, C. Y., Lin, W. S., Wu, C. Y., Lin, Y. H., Liu, W. C., Wu, S. C., & Sue, S. C. (2026). Circular Permutation of the E. coli Heat-Labile Enterotoxin Pentameric B Subunit for Mucosal Vaccine Adjuvant Design. ACS Omega, 11(5), 8784-8798. https://doi.org/10.1021/acsomega.5c12660

Vancouver

Hsu SH, Xie DY, Tsai CY, Lin WS, Wu CY, Lin YH, et al. Circular Permutation of the E. coli Heat-Labile Enterotoxin Pentameric B Subunit for Mucosal Vaccine Adjuvant Design. ACS Omega. 2026;11(5):8784-8798. doi:10.1021/acsomega.5c12660

BibTeX
@article{Hsu2026,
  author = {Hsu, Sheng-Han and Xie, Da-You and Tsai, Cheng-Yen and Lin, Wei-Shuo and Wu, Chu-Ya and Lin, Yi-Hung and Liu, Wen-Chun and Wu, Suh-Chin and Sue, Shih-Che},
  title = {Circular Permutation of the E. coli Heat-Labile Enterotoxin Pentameric B Subunit for Mucosal Vaccine Adjuvant Design},
  journal = {ACS Omega},
  year = {2026},
  volume = {11},
  number = {5},
  pages = {8784--8798},
  doi = {10.1021/acsomega.5c12660}
}
Kostenlos starten →